* Not a rare disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
autoimmune disorder that involves changes in the skin, blood vessels, muscles, and internal organs. There are two main types: localized scleroderma which affects only the skin; and systemic scleroderma which affects the blood vessels and internal organs, as well as the skin. Although the underlying cause of scleroderma is unknown, it is believed to relate to buildup of collagen in the skin and other organs, as a result of a faulty immune system response. There is no cure, but various treatments can relieve symptoms.Scleroderma is an
Last updated: 11/2/2015
- Borigini MJ. Scleroderma. MedlinePlus. 2014; http://www.nlm.nih.gov/medlineplus/ency/article/000429.htm.
- Scleroderma. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). 2010; http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp. Accessed 10/11/2010.
- Scleroderma. MayoClinic.com. 2008; http://www.mayoclinic.com/print/scleroderma/DS00362/DSECTION=all&METHOD=print. Accessed 10/11/2010.
- MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases. Click on the link to view information on this topic.
- The National Organization for Rare Disorders (NORD) is a federation of more than 130 nonprofit voluntary health organizations serving people with rare disorders. Click on the link to view information on this topic.
- Select volumes of the Scleroderma Care and Research Jounal can be viewed by visiting the Scleroderma Clinical Trials Consortium Web site. Click on the link above to learn more.